DeHe 前提 北京德恒（深圳）律师事务所 关于东芯半导体股份有限公司 2023 年限制性股票激励计划 北京德恒(深圳)律师事务所 预留授予部分第二个归属期符合归属条件、 2024 年限制性股票激励计划 预留授予部分第一个归属期符合归属条件 及作废部分限制性股票相关事项的 法律意见 北京德恒律师事务所 DeHeng Law Offices 关于东芯半导体股份有限公司 2023 年限制性股票激励计划预留授予部分第二个归属期符合归属条件、 2024 年限制性股票激励计划预留授予部分第一个归属期符合归属条件 及作废部分限制性股票相关事项的法律意见 深圳市福田区金田路 4018 号安联大厦 B 座 11 层 电话: 0755-88286488 传真: 0755-88286499 邮编: 518038 北京德恒(深圳)律师事务所 关于东芯半导体股份有限公司 2023 年限制性股票激励计划 预留授予部分第二个归属期符合归属条件、 2024 年限制性股票激励计划 预留授予部分第一个归属期符合归属条件 及作废部分限制性股票相关事项的 法律意见 德恒 06F20240197-00006 号 本法律意见仅供本次归属以及本次作废之 ...

Core Viewpoint - Dongxin Co., Ltd. reported a revenue of 230 million yuan in Q3 2025, marking a year-on-year increase of 27.03%, despite a net loss of 35.2158 million yuan [1] Financial Performance - For the first three quarters, the company achieved a revenue of 573 million yuan, reflecting a year-on-year growth of 28.09%, with a net loss of 146 million yuan [1] - The gross profit margin for the reporting period was 26.64%, which is an increase of 10.57 percentage points compared to the same period last year, and a rise of 4.62 percentage points from the previous quarter [1] Industry Context - The improvements in revenue and gross profit margin are attributed to the recovery in the semiconductor design industry and the rebound in downstream market demand, which facilitated effective product sales [1]

Group 1 - Dongxin Co., Ltd. (SH 688110) announced on October 28 that its third board meeting will be held on the same day, discussing the proposal to cancel certain restricted stocks [1] - For the year 2024, Dongxin's revenue composition is as follows: integrated circuits account for 99.75%, while other businesses account for 0.25% [1] - As of the report, Dongxin's market capitalization stands at 45 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation into a "slow bull" new pattern [1]

证券代码：688110 证券简称：东芯股份 公告编号：2025-070 东芯半导体股份有限公司 关于开展外汇套期保值业务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、交易情况概述 （一）交易目的 公司及全资子公司经营业务出口外汇结算业务量较大，主要以美元等外币结 算为主。当汇率出现较大波动时，汇兑损益将会对公司的经营业绩造成一定的影 响。 在此背景下，为有效规避外汇市场的风险，防范汇率大幅波动对公司经营业 绩造成不利影响，提高外汇资金使用效率，合理降低财务费用，公司及全资子公 司拟与银行等金融机构开展外汇套期保值业务。公司的外汇套期保值业务以正常 生产经营为基础，以规避和防范汇率风险为目的，不进行单纯以盈利为目的的投 机和套利交易。 交易主要情况 | 交易目的 | □获取投资收益 | | --- | --- | | | ☑套期保值（合约类别：□商品；☑外汇；□其他：________） | | | □其他：________ | | 交易品种 | 远期结售汇、外汇掉期、外汇期权、利率互换（利率掉期）、 ...

Financial Performance - The company achieved operating revenue of CNY 229.55 million in Q3 2025, representing a year-on-year increase of 27.03% and a quarter-on-quarter increase of 14.35%[9] - The gross profit margin for the period was 26.64%, an increase of 10.57 percentage points year-on-year and 4.62 percentage points quarter-on-quarter[9] - The total profit for the period was a loss of CNY 37.45 million, which is a reduction of CNY 5.67 million compared to the same period last year[10] - The net profit attributable to shareholders of the listed company was a loss of CNY 35.22 million, a decrease of CNY 4.00 million year-on-year[10] - Total operating revenue for the first three quarters of 2025 reached ¥572.54 million, a 28.1% increase from ¥446.99 million in the same period of 2024[32] - Net loss for the first three quarters of 2025 was ¥164.84 million, compared to a net loss of ¥136.50 million in the same period of 2024, representing a 20.8% increase in losses[34] - The company experienced a total comprehensive loss of ¥155.61 million, compared to a loss of ¥135.35 million in the same period last year[34] Research and Development - Research and development expenses totaled CNY 57.07 million, an increase of 9.31% compared to the same period last year[10] - The ratio of R&D expenses to operating revenue was 24.86%, a decrease of 4.03 percentage points year-on-year[8] - Research and development expenses were ¥162.50 million, slightly up from ¥157.97 million, indicating a continued focus on innovation[33] Cash Flow and Assets - The company reported a net cash flow from operating activities of CNY -167.80 million for the year-to-date[8] - Cash flow from operating activities showed a net outflow of ¥167.80 million, an improvement from a net outflow of ¥244.39 million in the previous year[36] - Cash and cash equivalents decreased to RMB 424.83 million from RMB 729.53 million as of December 31, 2024[27] - Cash and cash equivalents at the end of the period were ¥424.83 million, down from ¥1.02 billion at the end of the same period last year[37] - The company reported a significant increase in cash inflow from investment activities, totaling ¥1.34 billion, compared to ¥474.60 million in the previous year[36] - The net cash outflow from investment activities was ¥143.05 million, an improvement from a net outflow of ¥291.10 million in the same period last year[36] Shareholder Information - The total number of common shareholders at the end of the reporting period is 51,260[18] - The largest shareholder, Dongfang Hengxin Group Co., Ltd., holds 143,213,025 shares, accounting for 32.38% of total shares[18] - The second-largest shareholder, Suzhou Dongxin Kechuang Equity Investment Partnership, holds 22,500,000 shares, representing 5.09%[18] - The total number of shares held by the top ten shareholders is 203,000,000, which constitutes a significant portion of the company's total equity[19] Government Subsidies and Non-Operating Income - The total amount of government subsidies recognized in the current period is CNY 549,248.18, with a year-to-date total of CNY 6,731,851.80[15] - Non-operating income for the current period amounts to CNY 4,759,627.75, with a year-to-date total of CNY 20,515,120.66[15] - The impact of income tax on non-operating income for the year-to-date is CNY 3,809,172.01[15] - The company has not identified any significant non-operating income items not listed in the relevant disclosure guidelines[15] Equity and Liabilities - Total assets at the end of the reporting period were CNY 3.44 billion, a decrease of 2.67% compared to the end of the previous year[8] - As of September 30, 2025, the company's total assets amounted to RMB 3,436.65 million, a decrease from RMB 3,530.78 million as of December 31, 2024[27] - The company's total liabilities as of September 30, 2025, were RMB 179.13 million, compared to RMB 161.20 million as of December 31, 2024[29] - The company's equity attributable to shareholders amounted to RMB 3,110.67 million, a decrease from RMB 3,209.32 million as of December 31, 2024[29] Future Plans and Incentives - The company plans to invest approximately RMB 500 million in Shanghai Lishan, acquiring about 35.87% equity after the capital increase[21] - The company will contribute RMB 210.53 million to the capital increase, subscribing to an additional registered capital of approximately RMB 809,900[22] - The company has approved a restricted stock incentive plan for 2025, granting 899,800 shares at a price of RMB 82.05 per share to 141 incentive targets[23] - The company has also approved a stock appreciation rights incentive plan for 2025, granting 324,000 stock appreciation rights at an exercise price of RMB 82.05 per share to 7 incentive targets[24] Accounting Standards - The new accounting standards or interpretations will be implemented starting from 2025, affecting the financial statements from the beginning of the year[38]

东芯半导体股份有限公司董事会薪酬与考核委员会 关于公司 2023 年限制性股票激励计划预留授予部分第二个归属期及 2024 年限制性股票激励计划预留授予部分第一个归属期 公司2024年激励计划预留授予部分第一个归属期可归属的17名激励对象均 符合《公司法》《证券法》等法律法规、规范性文件及《公司章程》规定的任职 资格，符合《管理办法》《上市规则》等法律法规、规范性文件规定的激励对象 条件，符合 2024 年激励计划规定的激励对象范围，其作为公司 2024 年激励计划 激励对象的主体资格合法、有效，且 2024 年激励计划预留授予部分第一个归属 期归属条件已经成就。 综上，董事会薪酬与考核委员会同意为本次符合条件的预留授予 17 名激励 对象办理归属事宜，对应可归属的限制性股票数量为 4.8832 万股。上述事项符 合相关法律法规、规范性文件等相关规定，不存在损害公司及股东利益的情形。 东芯半导体股份有限公司董事会 薪酬与考核委员会 2025 年 10 月 28 日 东芯半导体股份有限公司（以下简称"公司"）董事会薪酬与考核委员会依 据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国 证券法 ...

证券代码：688110 证券简称：东芯股份 公告编号：2025-069 东芯半导体股份有限公司 第三届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 东芯半导体股份有限公司（以下简称"公司"）于 2025 年 10 月 28 日在公司 会议室以现场与通讯相结合方式召开了第三届董事会第六次会议（以下简称"本 次会议"）。本次会议的通知已于 2025 年 10 月 23 日以电子邮件或电话的方式送 达全体董事。本次会议由公司董事长蒋学明先生召集并主持，会议应出席董事 9 名，实际出席董事 9 名。本次会议的召集、召开程序和方式符合《公司法》等法 律法规以及《东芯半导体股份有限公司章程》的有关规定，会议决议合法、有效。 二、董事会会议审议情况 会议经与会董事审议并书面表决通过了如下议案： （二）审议通过《关于开展外汇套期保值业务的议案》 表决结果：9 票同意，0 票反对，0 票弃权，0 票回避。 以上具体内容详见同日披露于上海证券交易所网站（www.sse.com.cn）的《关 ...

证券代码：688110 证券简称：东芯股份 公告编号：2025-071 一、本次激励计划批准及实施情况 东芯半导体股份有限公司 关于 2023 年限制性股票激励计划预留授予部分 第二个归属期符合归属条件的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 东芯半导体股份有限公司（以下简称"公司"、"本公司"）于 2025 年 10 月 28 日召开的第三届董事会第六次会议，审议通过了《关于 2023 年限制性 股票激励计划预留授予部分第二个归属期符合归属条件的议案》，公司 2023 年限制性股票激励计划（以下简称"本次激励计划"）预留授予部分限制性股 票第二个归属期符合归属条件。现将有关事项说明如下： 2、授予数量：441.30 万股，其中，首次授予 401.70 万股，预留授予 39.60 万股 3、授予价格：21.874 元/股（调整后） 4、激励人数：144 人，其中，首次授予 117 人，预留授予 27 人 5、归属安排具体如下： 限制性股票拟归属数量：6.864 万股 归属股票来源：公司从二级市场 ...

Core Insights - The Shanghai Stock Exchange STAR Market 100 Index has shown a strong increase of 1.42%, with notable gains from stocks such as Guandun Quantum (+11.49%) and Dongxin Co. (+6.59%) [3] - The STAR 100 Index ETF (588030) has risen by 1.34%, reaching a latest price of 1.36 yuan, and has accumulated a weekly increase of 4.92% as of October 24, 2025 [3] - The liquidity of the STAR 100 Index ETF is robust, with a turnover rate of 1.59% and a transaction volume of 97.23 million yuan [3] Industry Developments - Significant breakthroughs have been made in the photoresist sector, crucial for integrated circuit chip manufacturing, with a team from Peking University successfully analyzing the micro-3D structure of photoresist molecules [3] - The domestic computing power industry continues to show strong performance, with leading companies like Cambrian and Haiguang Information reporting substantial growth in Q3 and maintaining a high growth trend for the year [4] - The approval of IPOs for companies like Muxi Co. and the previous approval for Moole Technology indicate a surge in demand within the AI computing sector [4] Market Performance - The STAR 100 Index ETF has reached a scale of 5.988 billion yuan, ranking 2nd among comparable funds [4] - The STAR 100 Index consists of 100 medium-sized, liquid stocks selected from the STAR Market, reflecting the overall performance of different market capitalization companies [4] - As of September 30, 2025, the top ten weighted stocks in the STAR 100 Index account for 24.32% of the index, including companies like Huahong Semiconductor and BeiGene [4]

Group 1 - The core viewpoint of the article highlights the performance of the Penghua Science and Technology Innovation 100 ETF, which reported a net value growth rate of 49.82% over the past year [1] - The fund's top ten holdings have seen changes, with new additions including Dongxin Co., Ltd., Yuanjie Technology, and Yuntian Lefe [1] - Huahong Technology remains the largest holding at 3.74% of the fund's portfolio, while Zexing Pharmaceutical, Naxin Micro, and Guodun Quantum have exited the top ten holdings [1] Group 2 - Detailed data on the fund's top holdings shows that Dongxin Co., Ltd. has entered the top ten with 1.872 million shares valued at 200 million yuan, and Yuanjie Technology has also entered with 362,500 shares valued at 156 million yuan [1] - Other notable changes include a reduction in holdings for Huahong Technology by 1.75%, with 2.4635 million shares valued at 282 million yuan, and a decrease in holdings for Baijie Shenzhou by 1.89% [1] - The fund's overall strategy reflects a shift in focus towards emerging technology companies, as indicated by the new additions and reductions in existing holdings [1]